Delivery Order SPE2DP20D0002-SPE2DP21F2053
Award Date 2/11/21
Potential Completion Date 2/23/21
Potential Value $424K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $141,176.88 firm fixed-price delivery order to provide Adenovirus Type 4 vaccine. This order was not set aside under any special socioeconomic program. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has an extensive history of providing drug products, including vaccines and respiratory medications, to federal agencies such as the Department of Defense...
- The Defense Logistics Agency Troop Support Medical awarded a $141,176.88 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc. to supply Adenovirus Type 4 vaccine. This award is not associated with a set-aside program. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has provided various drug products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of Defense and...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccines. The $135,747.00 contract has an August 25, 2020 completion date. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that has provided a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $146,823.93 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. This order supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, antivirals, respiratory treatments, and multiple sclerosis medications for federal customers...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to supply Adenovirus Type 4 vaccine. The $282,353.76 contract has a completion date of January 26, 2021. Teva Pharmaceuticals is a foreign-owned, for-profit organization that provides a range of drug products to federal agencies, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs. The...
- The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747.00 award has an October 27, 2020 completion date and was issued on October 19, 2020. This delivery order supports military immunization programs. Teva Pharmaceuticals USA, Inc. holds multiple indefinite delivery contracts with federal agencies, including a 5-year IDIQ with the...
- The Defense Logistics Agency Troop Support Medical has awarded a delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccines. The $587,295.72 firm fixed-price contract has a completion date of December 20, 2022 and was awarded on December 6, 2022. This award is not associated with a set-aside designation. Teva Pharmaceuticals USA, Inc. has a history of providing pharmaceutical products, including...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $407,241.00 order has a completion date of July 28, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that delivers patient-centric healthcare solutions, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit manufacturer, to provide Adenovirus Type 4 vaccine. The contract has a potential value of $407,241.00 and a completion date of December 15, 2020. Teva has supplied various pharmaceutical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to federal agencies such as the Department of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $271,494.00 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit manufacturer, to provide Adenovirus Type 4 vaccine. This order supports military immunization programs. Teva is an experienced federal contractor, having provided various pharmaceuticals to agencies like the Department of Defense and Department of Veterans Affairs through indefinite delivery contracts. Teva has also been...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP21F2053Delivery Order
The Defense Logistics Agency Troop Support Medical awarded a $423,530.64 firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc. to provide Adenovirus Type 4 vaccine. This order is not associated with a set-aside program. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has supplied various drug products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of Defense and Department of Veterans Affairs. The award has a completion date of February 23, 2021, indicating Teva will deliver the Adenovirus Type 4 vaccine to support military immunization programs.
Generated 3/23/24, 10:23 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
ADENOVIRUS TYPE 4 A | SPE2DP18R01130009 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 2/3/20, 2:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $423.5k | 2/11/21 |